
|Articles|June 7, 2020
AstraZeneca's Adrian Kilcoyne Discusses Small Lung Cancer (pt.2)
Author(s)Mary Caffrey
Advertisement
Adrian Kilcoyne MD MBA MPH, vice president, US Medical Affairs and HEOR, oncology, AstraZeneca, discusses small lung cancer and the presentation he held at the annual ASCO20 meeting in late May.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
2
Health Begins at Home: Why Housing Has Become a Strategic Priority for Managed Care
3
Consolidative radiotherapy shows no survival benefit, added risk in SCLC
4
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
5


























